Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001136261-17-000266
Filing Date
2017-11-07
Accepted
2017-11-07 16:49:39
Documents
72
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q body10q.htm 10-Q 753737
2 EMPLOYMENT AGREEMENT, DATED JULY 21, 2017, BY AND BETWEEN PERNIX THERAPEUTICS HO exh10-6.htm EX-10.6 77749
3 CEO 302 CERTIFICATE exh31-1.htm EX-31.1 5013
4 CFO 302 CERTIFICATE exh31-2.htm EX-31.2 4762
5 906 CERTIFICATE exh32-1.htm EX-32.1 3249
6 LOGO image1904.jpg GRAPHIC 6415
  Complete submission text file 0001136261-17-000266.txt   4281501

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT ptx-20170930.xml EX-101.INS 814662
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ptx-20170930.xsd EX-101.SCH 48466
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ptx-20170930_cal.xml EX-101.CAL 74757
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ptx-20170930_def.xml EX-101.DEF 118918
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ptx-20170930_lab.xml EX-101.LAB 398311
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ptx-20170930_pre.xml EX-101.PRE 284494
Mailing Address 10 NORTH PARK PLACE SUITE 201 MORRISTOWN NJ 07960
Business Address 10 NORTH PARK PLACE SUITE 201 MORRISTOWN NJ 07960 (862) 260-8457
PERNIX THERAPEUTICS HOLDINGS, INC. (Filer) CIK: 0001024126 (see all company filings)

EIN.: 330724736 | State of Incorp.: MD | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14494 | Film No.: 171184012
SIC: 2834 Pharmaceutical Preparations